OTEZLA® (apremilast) Significantly Improved Measures Of Disease Severity In Adults With Mild-To-Moderate Plaque Psoriasis
Go back to OTEZLA® (apremilast) Significantly Improved Measures Of Disease Severity In Adults With Mild-To-Moderate Plaque Psoriasis| Amgen Inc (NASDAQ: AMGN) | Delayed: 385.65 +5.87 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $379.78 | 52 Week High | $176.85 | |||
| Open | $378.51 | 52 Week Low | $133.64 | |||
| Day High | $386.50 | P/E | 58.08 | |||
| Day Low | $378.51 | EPS | $6.64 | |||
| Volume | 8,528,108 | |||||

